HIV co-receptor-tropism: cellular and molecular events behind the enigmatic co-receptor switching

References

• Agace WW, Amara A, Roberts AI, Pablos JL, Thelen S, Uguccioni M, Li XY, Marsal J, Arenzana-Seisdedos F, Delaunay T, et al. 2000. Constitutive expression of stromal derived factor-1 by mucosal epithelia and its role in HIV transmission and propagation. Curr Biol. 10:325–328
   PubMed Web of Science ®Google Scholar
• Aiamkitsumrit B, Dampier W, Martin-Garcia J, Nonnemacher MR, Pirrone V, Ivanova T, Zhong W, Kilareski E, Aldigun H, Frantz B, et al. 2014. Defining differential genetic signatures in cxcr4- and the ccr5-utilizing hiv-1 co-linear sequences. PLoS One. 9(9):e107389.
   PubMed Web of Science ®Google Scholar
• Álvarez Losada S, Cantó-Nogués C, Muñoz-Fernández MA. 2002. A new possible mechanism of human immunodeficiency virus type 1 infection of neural cells. Neurobiol Dis. 11:469–478.
   PubMed Web of Science ®Google Scholar
• Antell GC, Dampier W, Aiamkitsumrit B, Nonnemacher MR, Jacobson JM, Pirrone V, Zhong W, Kercher K, Passic S, Williams JW, et al. 2016. Utilization of HIV-1 envelope V3 to identify X4- and R5-specific Tat and LTR sequence signatures. Retrovirology. 13(1):32.
   PubMedGoogle Scholar
• Ashok Kumar M, Sonawane A, Sperk M, Tripathy SP, Neogi U, Hanna LE. 2020. In vitro replicative fitness of early transmitted founder HIV-1 variants and sensitivity to Interferon alpha. Sci Rep. 10(1):2747.
   PubMed Web of Science ®Google Scholar
• Ashokkumar M, Aralaguppe SG, Tripathy SP, Hanna LE, Neogi U. 2018. Unique phenotypic characteristics of recently transmitted HIV-1 subtype C envelope glycoprotein gp120: use of CXCR6 coreceptor by transmitted founder viruses. J Virol. 92(9):e00063-18.
   PubMed Web of Science ®Google Scholar
• Asin SN, Fanger MW, Wildt‐Perinic D, Ware PL, Wira CR, Howell AL. 2004. Transmission of HIV‐1 by primary human uterine epithelial cells and stromal fibroblasts. J INFECT Dis. 190(2):236–245.
   PubMed Web of Science ®Google Scholar
• Atluri VSR, Hidalgo M, Samikkannu T, Venkata KK, Jayant RD, Sagar V, Nair MPN. 2015. Effect of human immunodeficiency virus on blood-brain barrier integrity and function: an update. Front Cell Neurosci. 9:212.
   PubMed Web of Science ®Google Scholar
• Avalos CR, Price SL, Forsyth ER, Pin JN, Shirk EN, Bullock BT, Queen SE, Li M, Gellerup D, O’Connor SL, et al. 2016. Quantitation of productively infected monocytes and macrophages of simian immunodeficiency virus-infected macaques. J Virol. 90:5643–5656.
   PubMed Web of Science ®Google Scholar
• Ballweber L, Robinson B, Kreger A, Fialkow M, Lentz G, McElrath MJ, Hladik F. 2011. Vaginal langerhans cells nonproductively transporting HIV-1 mediate infection of T cells. J Virol. 85:13443–13447.
   PubMed Web of Science ®Google Scholar
• Bar KJ, Tsao C, Yen Iyer SS, Decker JM, Yang Y, Bonsignori M, Chen X, Hwang KK, Montefiori DC, Liao HX, et al. 2012. Early low-titer neutralizing antibodies impede HIV-1 replication and select for virus escape. PLoS Pathog. 8(5):e1002721.
   PubMed Web of Science ®Google Scholar
• Baxter AE, Russell RA, Duncan CJA, Moore MD, Willberg CB, Pablos JL, Finzi A, Kaufmann DE, Ochsenbauer C, Kappes JC, et al. 2014. Macrophage infection via selective capture of HIV-1-infected CD4+ T cells. Cell Host Microbe. 16:711–721.
   PubMed Web of Science ®Google Scholar
• Bernstein HB, Plasterer MC, Schiff SE, Kitchen CMR, Kitchen S, Zack JA. 2006. CD4 expression on activated NK cells: ligation of CD4 induces cytokine expression and cell migration. J Immunol. 177(6):3669–3676.
   PubMed Web of Science ®Google Scholar
• Bernstein HB, Wang G, Plasterer MC, Zack JA, Ramasastry P, Mumenthaler SM, Kitchen CMR. 2009. CD4+ NK cells can be productively infected with HIV, leading to downregulation of CD4 expression and changes in function. Virology. 387(1):59–66.
   PubMed Web of Science ®Google Scholar
• Bertram KM, Botting RA, Baharlou H, Rhodes JW, Rana H, Graham JD, Patrick E, Fletcher J, Plasto TM, Truong NR, et al. 2019. Identification of HIV transmitting CD11c + human epidermal dendritic cells. Nat Commun. 10(1):2759.
   PubMedGoogle Scholar
• Bissel SJ, Wiley CA. 2004. Human immunodeficiency virus infection of the brain: pitfalls in evaluating infected/affected cell populations. Brain Pathol. 14:97–108.
   PubMed Web of Science ®Google Scholar
• Borrajo A, Ranazzi A, Pollicita M, Concetta Bellocchi M, Salpini R, Mauro MV, Ceccherini-Silberstein F, Perno CF, Svicher V, Aquaro S. 2019. Different patterns of HIV-1 replication in MACROPHAGES is led by co-receptor usage. Medicina (Kaunas). 55:297.
   Web of Science ®Google Scholar
• Bracq L, Xie M, Lambelé M, Vu L-T, Matz J, Schmitt A, Delon J, Zhou P, Randriamampita C, Bouchet J, et al. 2017. T cell-macrophage fusion triggers multinucleated giant cell formation for HIV-1 spreading. J Virol. 91(24):e01237-17.
   PubMed Web of Science ®Google Scholar
• Budhiraja S, Famiglietti M, Bosque A, Planelles V, Rice AP. 2013. Cyclin T1 and CDK9 T-loop phosphorylation are downregulated during establishment of HIV-1 latency in primary resting memory CD4+ T cells. J Virol. 87:1211–1220.
   PubMed Web of Science ®Google Scholar
• Cafaro A, Tripiciano A, Picconi O, Sgadari C, Moretti S, Buttò S, Monini P, Ensoli B. 2019. Anti-tat immunity in HIV-1 infection: effects of naturally occurring and vaccine. Induced antibodies against Tat on the course of the disease. Vaccines. 7(3):99.
   Web of Science ®Google Scholar
• Cardaci S, Soster M, Bussolino F, Marchiò S. 2013. The V1/V2 loop of HIV-1 gp120 is necessary for Tat binding and consequent modulation of virus entry. FEBS Lett. 587:2943–2951.
   PubMed Web of Science ®Google Scholar
• Carter CC, McNamara LA, Onafuwa-Nuga A, Shackleton M, Riddell IJ, Bixby D, Savona MR, Morrison SJ, Collins KL. 2011. HIV-1 utilizes the CXCR4 chemokine receptor to infect multipotent hematopoietic stem and progenitor cells. Cell Host Microbe. 9:223–234.
   PubMed Web of Science ®Google Scholar
• Chang ST, Sova P, Peng X, Weiss J, Law GL, Palermo RE, Katze MG. 2011. Next-generation sequencing reveals HIV-1-mediated suppression of T cell activation and RNA processing and regulation of noncoding RNA expression in a CD4+ T cell line. MBio. 2(5):11.
   Web of Science ®Google Scholar
• Chevigne A, Delhalle S, Counson M, Beaupain N, Rybicki A, Verschueren C, Staub T, Schmit JC, Seguin-Devaux C, Deroo S. 2016. Isolation of an HIV-1 neutralizing peptide mimicking the CXCR4 and CCR5 surface from the heavy-chain complementary determining region 3 repertoire of a viremic controller. Aids. 30:377–382.
   PubMed Web of Science ®Google Scholar
• Chinnapaiyan S, Parira T, Dutta R, Agudelo M, Morris A, Nair M, Unwalla HJ. 2017. HIV infects bronchial epithelium and suppresses components of the mucociliary clearance apparatus. PLoS One. 12(1):e0169161.
   PubMed Web of Science ®Google Scholar
• Cicala C, Arthos J, Martinelli E, Censoplano N, Cruz CC, Chung E, Selig SM, Van Ryk D, Yang J, Jagannatha S, et al. 2006. R5 and X4 HIV envelopes induce distinct gene expression profiles in primary peripheral blood mononuclear cells. Proc Natl Acad Sci USA. 103(10):3746–3751.
   PubMed Web of Science ®Google Scholar
• Clark E, Nava B, Caputi M. 2017. Tat is a multifunctional viral protein that modulates cellular gene expression and functions. Oncotarget. 8(16):27569–27581.
   PubMedGoogle Scholar
• Conaldi PG, Serra C, Dolei A, Basolo F, Falcone V, Mariani G, Speziale P, Toniolo A. 1995. Productive HIV‐1 infection of human vascular endothelial cells requires cell proliferation and is stimulated by combined treatment with interleukin‐1β plus tumor necrosis factor. J Med Virol. 47:355–363.
   PubMed Web of Science ®Google Scholar
• Connell BJ, Hermans LE, Wensing AMJ, Schellens I, Schipper PJ, van Ham PM, de Jong DTCM, Otto S, Mathe T, Moraba R, et al. 2020. Immune activation correlates with and predicts CXCR4 co-receptor tropism switch in HIV-1 infection. Sci Rep. 10(1).
   Web of Science ®Google Scholar
• Connell BJ, Lortat-Jacob H. 2013. Human immunodeficiency virus and heparan sulfate: From attachment to entry inhibition. Front Immunol. 4:385.
   PubMed Web of Science ®Google Scholar
• Cornelissen M, Mulder-Kampinga G, Veenstra J, Zorgdrager F, Kuiken C, Hartman S, Dekker J, van der Hoek L, Sol C, Coutinho R. 1995. Syncytium-inducing (SI) phenotype suppression at seroconversion after intramuscular inoculation of a non-syncytium-inducing/SI phenotypically mixed human immunodeficiency virus population. J Virol. 69(3):1810–1818.
   PubMed Web of Science ®Google Scholar
• Creson JR, Lin AA, Li Q, Broad DF, Roberts MR, Anderson SJ. 1999. The mode and duration of anti-CD28 costimulation determine resistance to infection by macrophage-tropic strains of human immunodeficiency virus type 1 in vitro. J Virol. 73:9337–9347.
   PubMed Web of Science ®Google Scholar
• Crisci E, Svanberg C, Ellegård R, Khalid M, Hellblom J, Okuyama K, Bhattacharya P, Nyström S, Shankar EM, Eriksson K, et al. 2019. HSV-2 cellular programming enables productive HIV infection in dendritic cells. Front Immunol. 10:2889.
   PubMed Web of Science ®Google Scholar
• Cuevas JM, Geller R, Garijo R, López-Aldeguer J, Sanjuán R. 2015. Extremely high mutation rate of HIV-1 in vivo. PLoS Biol. 13(9):e1002251.
   PubMed Web of Science ®Google Scholar
• De Silva FS, Venturini DS, Wagner E, Shank PR, Sharma S. 2001. CD4-independent infection of human B cells with HIV type 1: detection of unintegrated viral DNA. AIDS Res Hum Retroviruses. 17:1585–1598.
   PubMed Web of Science ®Google Scholar
• Dimonte S, Mercurio F, Svicher V, D'Arrigo R, Perno C-F, Ceccherini-Silberstein F. 2011. Selected amino acid mutations in HIV-1 B subtype gp41 are associated with specific gp120V3signatures in the regulation of co-receptor usage. Retrovirology. 8(1):33.
   PubMedGoogle Scholar
• Dorosko SM, Connor RI. 2010. Primary human mammary epithelial cells endocytose hiv-1 and facilitate viral infection of CD4 + T lymphocytes. JVI. 84(20):10533–10542.
   PubMed Web of Science ®Google Scholar
• Duncan CJA, Sattentau QJ. 2011. Viral determinants of HIV-1 macrophage tropism. Viruses. 3(11):2255–2279.
   PubMed Web of Science ®Google Scholar
• Eitner F, Cui Y, Hudkins KL, Stokes MB, Segerer S, Mack M, Lewis PL, Abraham AA, Schlöndorff D, Gallo G, et al. 2000. Chemokine receptor CCR5 and CXCR4 expression in HIV-associated kidney disease. J Am Soc Nephrol. 11:856–867.
   PubMed Web of Science ®Google Scholar
• Farzan M, Babcock GJ, Vasilieva N, Wright PL, Kiprilov E, Mirzabekov T, Choe H. 2002. The role of post-translational modifications of the CXCR4 amino terminus in stromal-derived factor 1α association and HIV-1 entry. J Biol Chem. 277:29484–29489.
   PubMed Web of Science ®Google Scholar
• Fätkenheuer G, Nelson M, Lazzarin A, Konourina I, Hoepelman AIM, Lampiris H, Hirschel B, Tebas P, Raffi F, Trottier B, et al. 2008. Subgroup analyses of Maraviroc in previously treated R5 HIV-1 infection. N Engl J Med. 359(14):1442–1455.
   PubMed Web of Science ®Google Scholar
• Foster TL, Wilson H, Iyer SS, Coss K, Doores K, Smith S, Kellam P, Finzi A, Borrow P, Hahn BH, et al. 2016. Resistance of transmitted founder HIV-1 to IFITM-mediated restriction. Cell Host Microbe. 20:429–442.
   PubMed Web of Science ®Google Scholar
• Fransen S, Bridger G, Whitcomb JM, Toma J, Stawiski E, Parkin N, Petropoulos CJ, Huang W. 2008. Suppression of dualtropic human immunodeficiency virus type 1 by the CXCR4 antagonist AMD3100 is associated with efficiency of CXCR4 use and baseline virus composition. AAC. 52(7):2608–2615.
   Google Scholar
• Ganesh L, Leung K, Lore K, Levin R, Panet A, Schwartz O, Koup RA, Nabel GJ. 2004. Infection of specific dendritic cells by CCR5-tropic human immunodeficiency virus type 1 promotes cell-mediated transmission of virus resistant to broadly neutralizing antibodies. JVI. 78(21):11980–11987.
   PubMed Web of Science ®Google Scholar
• Ganor Y, Real F, Sennepin A, Dutertre CA, Prevedel L, Xu L, Tudor D, Charmeteau B, Couedel-Courteille A, Marion S, et al. 2019. HIV-1 reservoirs in urethral macrophages of patients under suppressive antiretroviral therapy. Nat Microbiol. 4(4):633–644.
   PubMed Web of Science ®Google Scholar
• Gorry PR, Francella N, Lewin SR, Collman RG. 2014. HIV-1 envelope-receptor interactions required for macrophage infection and implications for current HIV-1 cure strategies. J Leukoc Biol. 95(1):71–81.
   PubMed Web of Science ®Google Scholar
• Gorry P, McPhee D, Wesselingh S, Churchill M. 2007. Macrophage tropism and cytopathicity of HIV-1 variants isolated sequentially from a long-term survivor infected with nef-deleted virus. Open Microbiol J. 1:1–7.
   PubMedGoogle Scholar
• Gray ES, Moody MA, Wibmer CK, Chen X, Marshall D, Amos J, Moore PL, Foulger A, Yu J-S, Lambson B, et al. 2011. Isolation of a monoclonal antibody that targets the alpha-2 helix of gp120 and represents the initial autologous neutralizing-antibody response in an HIV-1 subtype C-infected individual. J Virol. 85:7719–7729.
   PubMed Web of Science ®Google Scholar
• Gringhuis SI, Van Der Vlist M, Van Den Berg LM, Den Dunnen J, Litjens M, Geijtenbeek TBH. 2010. HIV-1 exploits innate signaling by TLR8 and DC-SIGN for productive infection of dendritic cells. Nat Immunol. 11(5):419–426.
   PubMed Web of Science ®Google Scholar
• Gulzar N, Balasubramanian S, Harris G, Sanchez-Dardon J, Copeland KFT. 2008. Infection of CD8 + CD45RO + memory T-cells by HIV-1 and their proliferative response. Open Aids J. 2(1):43–57.
   PubMedGoogle Scholar
• Herate C, Vigne C, Guenzel CA, Lambele M, Rouyez MC, Benichou S. 2016. Uracil DNA glycosylase interacts with the p32 subunit of the replication protein A complex to modulate HIV-1 reverse transcription for optimal virus dissemination. Retrovirology. 13(1):26.
   PubMedGoogle Scholar
• Herrera R, Morris M, Rosbe K, Feng Z, Weinberg A, Tugizov S. 2016. Human beta-defensins 2 and -3 cointernalize with human immunodeficiency virus via heparan sulfate proteoglycans and reduce infectivity of intracellular virions in tonsil epithelial cells. Virology. 487:172–187.
   PubMed Web of Science ®Google Scholar
• Hua Xiang S, Pacheco B, Bowder D, Yuan W, Sodroski J. 2013. Characterization of a dual-tropic Human immunodeficiency virus (HIV-1) strain derived from the prototypical X4 isolate HXBc2. Virology. 438(1):5–13.
   PubMed Web of Science ®Google Scholar
• Huang W, Eshleman SH, Toma J, Fransen S, Stawiski E, Paxinos EE, Whitcomb JM, Young AM, Donnell D, Mmiro F, et al. 2007. Coreceptor tropism in human immunodeficiency virus type 1 subtype D: high prevalence of CXCR4 tropism and heterogeneous composition of viral populations. JVI. 81(15):7885–7893.
   PubMed Web of Science ®Google Scholar
• Iliopoulou M, Nolan R, Alvarez L, Watanabe Y, Coomer CA, Jakobsdottir GM, Bowden TA, Padilla-Parra S. 2018. A dynamic three-step mechanism drives the HIV-1 pre-fusion reaction. Nat Struct Mol Biol. 25(9):814–822.
   PubMed Web of Science ®Google Scholar
• Imlach S, McBreen S, Shirafuji T, Leen C, Bell JE, Simmonds P. 2001. Activated peripheral CD8 lymphocytes express CD4 in vivo and are targets for infection by human immunodeficiency virus type 1. J Virol. 75(23):11555–11564.
   PubMed Web of Science ®Google Scholar
• Isaacman-Beck J, Hermann EA, Yi Y, Ratcliffe SJ, Mulenga J, Allen S, Hunter E, Derdeyn CA, Collman RG. 2009. Heterosexual transmission of human immunodeficiency virus type 1 subtype C: macrophage tropism, alternative coreceptor use, and the molecular anatomy of CCR5 utilization. J Virol. 83(16):8208–8220.
   PubMed Web of Science ®Google Scholar
• Jones KL, Roche M, Gantier MP, Begum NA, Honjo T, Caradonna S, Williams BRG, Mak J. 2010. X4 and R5 HIV-1 have distinct post-entry requirements for uracil DNA glycosylase during infection of primary cells. J Biol Chem. 285(24):18603–18614.
   PubMed Web of Science ®Google Scholar
• Joseph SB, Swanstrom R. 2018. The evolution of HIV-1 entry phenotypes as a guide to changing target cells. J Leukoc Biol. 103(3):421–431.
   PubMed Web of Science ®Google Scholar
• Joseph SB, Swanstrom R, Kashuba ADM, Cohen MS. 2015. Bottlenecks in HIV-1 transmission: Insights from the study of founder viruses. Nat Rev Microbiol. 13(7):414–425.
   PubMed Web of Science ®Google Scholar
• Kalinina OV, Pfeifer N, Lengauer T. 2013. Modelling binding between CCR5 and CXCR4 receptors and their ligands suggests the surface electrostatic potential of the co-receptor to be a key player in the HIV-1 tropism. Retrovirology. 10:130.
   PubMed Web of Science ®Google Scholar
• Karris MAY, Smith DM. 2011. Tissue-specific HIV-1 infection: Why it matters. Future Virol. 6:869–882.
   PubMed Web of Science ®Google Scholar
• Kaul M, Ma Q, Medders KE, Desai MK, Lipton SA. 2007. HIV-1 coreceptors CCR5 and CXCR4 both mediate neuronal cell death but CCR5 paradoxically can also contribute to protection. Cell Death Differ. 14(2):296–305.
   PubMed Web of Science ®Google Scholar
• Ke Z, Ana Rachel L, Lily T, Heather K, Carole H, Agegnehu G, James B, Susan W, Cecilia C-M, Silvestri G. 2014. Emergence of CD4 independence envelopes and astrocyte infection in R5 simian-human immunodeficiency virus model of encephalitis. J Virol..
   Web of Science ®Google Scholar
• Kouyos RD, Rusert P, Kadelka C, Huber M, Marzel A, Ebner H, Schanz M, Liechti T, Friedrich N, Braun DL, et al. 2018. Tracing HIV-1 strains that imprint broadly neutralizing antibody responses. Nature. 561(7723):406–410.
   PubMed Web of Science ®Google Scholar
• Li Y, Deng L, Liang J, Dong G-H, Xia Y-L, Fu Y-X, Liu S-Q. 2020. Molecular dynamics simulations reveal distinct differences in conformational dynamics and thermodynamics between the unliganded and CD4-bound states of HIV-1 gp120. Phys Chem Chem Phys. 22(10):5548–5560.
   PubMed Web of Science ®Google Scholar
• Li G-H, Henderson L, Nath A. 2016. Astrocytes as an HIV Reservoir: Mechanism of HIV Infection. Curr HIV Res. 14:373–381.
   PubMed Web of Science ®Google Scholar
• Li GH, Maric D, Major EO, Nath A. 2020. Productive HIV infection in astrocytes can be established via a nonclassical mechanism. Aids. 34(7):963–978.
   PubMed Web of Science ®Google Scholar
• Lin N, Gonzalez OA, Registre L, Becerril C, Etemad B, Lu H, Wu X, Lockman S, Essex M, Moyo S, et al. 2016. Humoral immune pressure selects for HIV-1 CXC-chemokine receptor 4-using variants. EBioMedicine. 8:237–247.
   PubMed Web of Science ®Google Scholar
• Liu Y, Cao W, Sun M, Li T. 2020. Broadly neutralizing antibodies for HIV-1: efficacies, challenges and opportunities. Emerg Microbes Infect. 9:194–206.
   PubMed Web of Science ®Google Scholar
• Llewellyn GN, Alvarez-Carbonell D, Chateau M, Karn J, Cannon PM. 2018. HIV-1 infection of microglial cells in a reconstituted humanized mouse model and identification of compounds that selectively reverse HIV latency. J Neurovirol. 24:192–203.
   PubMed Web of Science ®Google Scholar
• Locher CP, Witt SA, Kassel R, Dowell NL, Fujimura S, Levy JA. 2005. Differential effects of R5 and X4 human immunodeficiency virus type 1 infection on CD4+ cell proliferation and activation. J Gen Virol. 86:1171–1179.
   PubMed Web of Science ®Google Scholar
• Lopes De Campos WR, Chirwa N, London G, Rotherham LS, Morris L, Mayosi BM, Khati M. 2014. HIV-1 subtype C unproductively infects human cardiomyocytes in vitro and induces apoptosis mitigated by an anti-gp120 aptamer. PLoS One. 9(10):e110930.
   PubMed Web of Science ®Google Scholar
• Lundquist CA, Zhou J, Aiken C. 2004. Nef stimulates human immunodeficiency virus type 1 replication in primary T cells by enhancing virion-associated gp120 levels: coreceptor-dependent requirement for Nef in viral replication. JVI. 78(16):8950–8950.
   Web of Science ®Google Scholar
• Marcus JL, Leyden WA, Alexeeff SE, Anderson AN, Hechter RC, Hu H, Lam JO, Towner WJ, Yuan Q, Horberg MA, et al. 2020. Comparison of overall and comorbidity-free life expectancy between insured adults with and without HIV infection, 2000–2016. JAMA Netw Open. 3(6):e207954.
   PubMed Web of Science ®Google Scholar
• Margolis L, Shattock R. 2006. Selective transmission of CCR5-utilizing HIV-1: the “gatekeeper” problem resolved? Nat Rev Microbiol. 4(4):312–317.
   PubMed Web of Science ®Google Scholar
• Mazzuca P, Caruso A, Caccuri F. 2016. HIV-1 infection, microenvironment and endothelial cell dysfunction. New Microbiol. 39:163–173.
   PubMed Web of Science ®Google Scholar
• McBreen S, Imlach S, Shirafuji T, Scott GR, Leen C, Bell JE, Simmonds P. 2001. Infection of the CD45RA+ (Naive) subset of peripheral CD8+ lymphocytes by human immunodeficiency virus type 1 in vivo. J Virol. 75(9):4091–4102.
   PubMed Web of Science ®Google Scholar
• Meijerink H, Indrati AR, van Crevel R, Joosten I, Koenen H, van der Ven AJAM. 2014. The number of CCR5 expressing CD4+ T lymphocytes is lower in HIV-infected long-term non-progressors with viral control compared to normal progressors: a cross-sectional study. BMC Infect Dis. 14(1):683.
   PubMedGoogle Scholar
• Micsenyi AM, Zony C, Alvarez RA, Durham ND, Chen BK, Klotman ME. 2013. Postintegration HIV-1 infection of cervical epithelial cells mediates contact-dependent productive infection of t cells. J Infect Dis. 208:1756–1767.
   PubMed Web of Science ®Google Scholar
• Moir S, Fauci AS. 2009. B cells in HIV infection and disease. Nat Rev Immunol. 9(4):235–245.
   PubMed Web of Science ®Google Scholar
• Monini P, Cafaro A, Srivastava IK, Moretti S, Sharma VA, Andreini C, Chiozzini C, Ferrantelli F, Cossut MRP, Tripiciano A, et al. 2012. HIV-1 Tat promotes integrin-mediated HIV transmission to dendritic cells by binding Env spikes and competes neutralization by anti-HIV antibodies. PLoS One. 7(11):e48781.
   PubMed Web of Science ®Google Scholar
• Moore PL, Gray ES, Choge IA, Ranchobe N, Mlisana K, Abdool Karim SS, Williamson C, Morris L. 2008. The C3-V4 region is a major target of autologous neutralizing antibodies in human immunodeficiency virus type 1 subtype C infection. JVI. 82(4):1860–1869.
   PubMed Web of Science ®Google Scholar
• Mosier DE. 2009. How HIV changes its tropism: evolution and adaptation? Curr Opin HIV AIDS. 4:125–130.
   PubMed Web of Science ®Google Scholar
• Nelson CR-KWA. 1991. In: Diizgiine§ N editor. Cells infected by human immunodeficiency virus in vivo. 1st ed. New York, Boston (MA): Springer..
   Google Scholar
• Nicholson JKA, Cross GD, Callaway CS, McDougal JS. 1986. In vitro infection of human monocytes with human T lymphotropic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV). J Immunol. 137:323–329.
   PubMed Web of Science ®Google Scholar
• Nina L, Ludy R, Manish S. 2019. HIV co-receptor usage, broadly neutralising antibodies, and treatment. EMJ Allergy Immunol. 4:117–125.
   Google Scholar
• Omi K, Shimizu M, Watanabe E, Matsumura J, Takaku C, Shinya E, Takahashi H. 2014. Inhibition of R5-tropic HIV type-1 replication in CD4+ natural killer T cells by γδ T lymphocytes. Immunology. 141(4):596–608.
   PubMed Web of Science ®Google Scholar
• Panos G, Watson DC. 2015. Effect of HIV-1 subtype and tropism on treatment with chemokine coreceptor entry inhibitors; overview of viral entry inhibition. Crit Rev Microbiol. 41:473–487.
   PubMed Web of Science ®Google Scholar
• Parisi SG, Andreoni C, Sarmati L, Boldrin C, Buonomini AR, Andreis S, Scaggiante R, Cruciani M, Bosco O, Manfrin V, et al. 2011. HIV coreceptor tropism in paired plasma, peripheral blood mononuclear cell, and cerebrospinal fluid isolates from antiretroviral-naïve subjects. J Clin Microbiol.
   Web of Science ®Google Scholar
• Parrish NF, Gao F, Li H, Giorgi EE, Barbian HJ, Parrish EH, Zajic L, Iyer SS, Decker JM, Kumar A, et al. 2013. Phenotypic properties of transmitted founder HIV-1. Proc Natl Acad Sci U S A. 110:6626–6633.
   PubMed Web of Science ®Google Scholar
• Pfeifer N, Walter H, Lengauer T. 2014. Association between HIV-1 coreceptor usage and resistance to broadly neutralizing antibodies. J Acquir Immune Defic Syndr. 67:107–112.
   PubMed Web of Science ®Google Scholar
• Pollakis G, Abebe A, Kliphuis A, Chalaby MIM, Bakker M, Mengistu Y, Brouwer M, Goudsmit J, Schuitemaker H, Paxton WA. 2004. Phenotypic and genotypic comparisons of CCR5- and CXCR4-tropic human immunodeficiency virus type 1 biological clones isolated from subtype C-infected individuals. JVI. 78(6):2841–2852.
   PubMed Web of Science ®Google Scholar
• Pollakis G, Kang S, Kliphuis A, Chalaby MIM, Goudsmit J, Paxton WA. 2001. N-linked glycosylation of the HIV type-1 gp120 envelope glycoprotein as a major determinant of CCR5 and CXCR4 coreceptor utilization. J Biol Chem. 276:13433–13441.
   PubMed Web of Science ®Google Scholar
• Prakash M, Kapembwa MS, Gotch F, Patterson S. 2004. Chemokine receptor expression on mucosal dendritic cells from the endocervix of healthy women. J INFECT Dis. 190(2):246–250.
   PubMed Web of Science ®Google Scholar
• Registre L, Moreau Y, Ataca ST, Pulukuri S, Henrich TJ, Lin N, Sagar M. 2019. HIV-1 coreceptor usage and variable loop contact impact V3 loop broadly neutralizing antibody susceptibility. J Virol. 94(2):e01604-19.
   Web of Science ®Google Scholar
• Regoes RR, Bonhoeffer S. 2005. The HIV coreceptor switch: A population dynamical perspective. Trends Microbiol. 13(6):269–277.
   PubMed Web of Science ®Google Scholar
• Richman DD, Wrin T, Little SJ, Petropoulos CJ. 2003. Rapid evolution of the neutralizing antibody response to HIV type 1 infection. Proc Natl Acad Sci USA. 100: 4144–4149.
   PubMed Web of Science ®Google Scholar
• Rojas-Celis V, Valiente-Echeverría F, Soto-Rifo R, Toro-Ascuy D. 2019. New challenges of HIV-1 infection: how HIV-1 attacks and resides in the central nervous system. Cells. 8(10):1245.
   PubMed Web of Science ®Google Scholar
• Rong R, Li B, Lynch RM, Haaland RE, Murphy MK, Mulenga J, Allen SA, Pinter A, Shaw GM, Hunter E, et al. 2009. Escape from autologous neutralizing antibodies in acute/early subtype C HIV-1 infection requires multiple pathways. PLoS Pathog. 5(9):e1000594.
   PubMed Web of Science ®Google Scholar
• Ross MD, Bruggeman LA, Hanss B, Sunamoto M, Marras D, Klotman ME, Klotman PE. 2003. Podocan, a novel small leucine-rich repeat protein expressed in the sclerotic glomerular lesion of experimental HIV-associated nephropathy. J Biol Chem. 278:33248–33255.
   PubMed Web of Science ®Google Scholar
• Rowland-Jones S, Andrews SM. 2017. Recent advances in understanding HIV evolution. F1000Res. 6:597.
   PubMedGoogle Scholar
• Sagar M, Wu X, Lee S, Overbaugh J. 2006. Human immunodeficiency virus type 1 V1-V2 envelope loop sequences expand and add glycosylation sites over the course of infection, and these modifications affect antibody neutralization sensitivity. JVI. 80(19):9586–9598.
   PubMed Web of Science ®Google Scholar
• Saha K, Zhang J, Gupta A, Dave R, Yimen M, Zerhouni B. 2001. Isolation of primary HIV-1 that target CD8+ T lymphocytes using CD8 as a receptor. Nat Med. 7(1):65–72.
   PubMed Web of Science ®Google Scholar
• Schiavoni I, Trapp S, Santarcangelo AC, Piacentini V, Pugliese K, Baur A, Federico M. 2004. HIV-1 Nef enhances both membrane expression and virion incorporation of Env products: a model for the Nef-dependent increase of HIV-1 infectivity. J Biol Chem. 279:22996–23006.
   PubMed Web of Science ®Google Scholar
• Schmökel J, Li H, Shabir A, Yu H, Geyer M, Silvestri G, Sodora DL, Hahn BH, Kirchhoff F. 2013. Link between primate lentiviral coreceptor usage and Nef function. Cell Rep. 5:997–1009.
   PubMed Web of Science ®Google Scholar
• Schnur E, Noah E, Ayzenshtat I, Sargsyan H, Inui T, Ding FX, Arshava B, Sagi Y, Kessler N, Levy R, et al. 2011. The conformation and orientation of a 27-residue CCR5 peptide in a ternary complex with HIV-1 gp120 and a CD4-mimic peptide. J Mol Biol. 410:778–797.
   PubMed Web of Science ®Google Scholar
• Schweighardt B, Roy A-M, Meiklejohn DA, Grace EJ, Moretto WJ, Heymann JJ, Nixon DF. 2004. R5 human immunodeficiency virus type 1 (HIV-1) replicates more efficiently in primary CD4+ T-cell cultures than X4 HIV-1. JVI. 78(17):9164–9173.
   PubMed Web of Science ®Google Scholar
• Seidel A, Ye Y, de Armas LR, Soto M, Yarosh W, Marcsisin RA, Tran D, Selsted ME, Camerini D. 2010. Cyclic and acyclic defensins inhibit human immunodeficiency virus type-1 replication by different mechanisms. PLoS One. 5(3):e9737.
   PubMed Web of Science ®Google Scholar
• Sepúlveda-Crespo D, Ceña-Díez R, Jiménez JL, Ángeles Muñoz-Fernández M. 2017. Mechanistic studies of viral entry: an overview of Dendrimer-based microbicides as entry inhibitors against both HIV and HSV-2 overlapped infections. Med Res Rev. 37:149–179.
   PubMed Web of Science ®Google Scholar
• Shaik MM, Peng H, Lu J, Rits-Volloch S, Xu C, Liao M, Chen B. 2019. Structural basis of coreceptor recognition by HIV-1 envelope spike. Nature. 565(7739):318–323.
   PubMed Web of Science ®Google Scholar
• Shen HS, Yin J, Leng F, Teng RF, Xu C, Xia XY, Pan XM. 2016. HIV coreceptor tropism determination and mutational pattern identification. Sci Rep. 6:21280.
   PubMed Web of Science ®Google Scholar
• Simek MD, Rida W, Priddy FH, Pung P, Carrow E, Laufer DS, Lehrman JK, Boaz M, Tarragona-Fiol T, Miiro G, et al. 2009. Human immunodeficiency virus type 1 elite neutralizers: individuals with broad and potent neutralizing activity identified by using a high-throughput neutralization assay together with an analytical selection algorithm. JVI. 83(14):7337–7348.
   PubMed Web of Science ®Google Scholar
• Sina ST, Ren W, Cheng-Mayer C. 2010. Coreceptor use in nonhuman primate models of HIV infection. J Transl Med. 9(Suppl 1):S7.
   Google Scholar
• Sirois M, Robitaille L, Sasik R, Estaquier J, Fortin J, Corbeil J. 2008. R5 and X4 HIV viruses differentially modulate host gene expression in resting CD4+ T cells. AIDS Res Hum Retroviruses. 24:485–493.
   PubMed Web of Science ®Google Scholar
• Song H, Hora B, Giorgi EE, Kumar A, Cai F, Bhattacharya T, Perelson AS, Gao F. 2016. Transmission of multiple HIV-1 subtype C transmitted/founder viruses into the same recipients was not determined by modest phenotypic differences. Sci Rep. 6(1):38130.
   PubMedGoogle Scholar
• Stins MF, Pearce D, Hee-Jung-Choi A, Di CF, Pardo CA, Kim KS. 2004. CD4 and chemokine receptors on human brain microvascular endothelial cells, implications for human immunodeficiency virus type 1 pathogenesis. Endothel J Endothel Cell Res. 11:275–284.
   PubMed Web of Science ®Google Scholar
• Terrasse R, Memmi M, Palle S, Heyndrickx L, Vanham G, Pozzetto B, Bourlet T. 2017. Visualization of X4- and R5-Tropic HIV-1 viruses expressing fluorescent proteins in human endometrial cells: application to tropism study. PLoS One. 12(1):e0169453.
   PubMed Web of Science ®Google Scholar
• Valentin A, Rosati M, Patenaude DJ, Hatzakis A, Kostrikis LG, Lazanas M, Wyvill KM, Yarchoan R, Pavlakis GN. 2002. Persistent HIV-1 infection of natural killer cells in patients receiving highly active antiretroviral therapy. Proc Natl Acad Sci U S A. 99:7015–7020.
   PubMed Web of Science ®Google Scholar
• Van’t Wout AB, Kootstra NA, Mulder-Kampinga GA, Albrecht-Van Lent N, Scherpbier HJ, Veenstra J, Boer K, Coutinho RA, Miedema F. Schuitemaker H. 1994. Macrophage-tropic variants initiate human immunodeficiency virus type 1 infection after sexual, parenteral, and vertical transmission. J Clin Invest. 94:2060–2067.
   PubMed Web of Science ®Google Scholar
• Vlahakis SR, Villasis‐Keever A, Gomez TS, Bren GD, Paya CV. 2003. Human immunodeficiency virus–induced apoptosis of human hepatocytes via CXCR4. J Infect Dis. 188(10):1455–1460.
   PubMed Web of Science ®Google Scholar
• Wallet C, De Rovere M, Van Assche J, Daouad F, De WS, Gautier V, Mallon PWG, Marcello A, Van Lint C, Rohr O, et al. 2019. Microglial cells: the main HIV-1 reservoir in the brain. Front Cell Infect Microbiol. 9:362.
   PubMed Web of Science ®Google Scholar
• Wang J-H, Janas AM, Olson WJ, KewalRamani VN, Wu L. 2007. CD4 coexpression regulates DC-SIGN-mediated transmission of human immunodeficiency virus type 1. JVI. 81(17):8933–8943.
   PubMedGoogle Scholar
• Watt G, Kantipong P, Burnouf T, Shikuma C, Philpott S. 2013. Natural scrub typhus antibody suppresses HIV CXCR4(X4) viruses. Infect Dis Rep. 5(1):8.
   Google Scholar
• Wei X, Decker JM, Wang S, Hui H, Kappes JC, Wu X, Salazar-Gonzalez JF, Salazar MG, Kilby JM, Saag MS, et al. 2003. Antibody neutralization and escape by HIV-1. Nature. 423(6936):197–197.
   Web of Science ®Google Scholar
• Wu Y. 2009. The co-receptor signaling model of HIV-1 pathogenesis in peripheral CD4 T cells. Retrovirology. 6:41.
   PubMed Web of Science ®Google Scholar
• Wu WL, Grotefend CR, Tsai MT, Wang YL, Radic V, Eoh H, Huang IC. 2017. Δ20 IFITM2 differentially restricts X4 and R5 HIV-1. Proc Natl Acad Sci USA. 114:7112–7117.
   PubMed Web of Science ®Google Scholar
• Xiao H, Neuveut C, Tiffany HL, Benkirane M, Rich EA, Murphy PM, Jeang KT. 2000. Selective CXCR4 antagonism by Tat: Implications for in vivo expansion of coreceptor use by HIV-1. Proc Natl Acad Sci USA. 97(21):11466–11471.
   PubMed Web of Science ®Google Scholar
• Xie M, Leroy H, Mascarau R, Woottum M, Dupont M, Ciccone C, Schmitt A, Raynaud-Messina B, Vérollet C, Bouchet J, et al. 2019. Cell-to-cell spreading of HIV-1 in myeloid target cells escapes SAMHD1 restriction. MBio. 10(6):e02457-19.
   PubMed Web of Science ®Google Scholar
• Yasen A, Herrera R, Rosbe K, Lien K, Tugizov SM. 2018. HIV internalization into oral and genital epithelial cells by endocytosis and macropinocytosis leads to viral sequestration in the vesicles. Virology. 515:92–107.
   PubMed Web of Science ®Google Scholar
• Zerhouni B, Nelson JAE, Saha K. 2004. Isolation of CD4-independent primary human immunodeficiency virus type 1 isolates that are syncytium inducing and acutely cytopathic for CD8+ lymphocytes. J Virol. 78:1243–1255.
   PubMedGoogle Scholar
• Zhang ZQ, Schuler T, Zupancic M, Wietgrefe S, Staskus KA, Reimann KA, Reinhart TA, Rogan M, Cavert W, Miller CJ, et al. 1999. Sexual transmission and propagation of SIV and HIV in resting and activated CD4+ T cells. Science. 286(5443):1353–1357.
   Google Scholar
• Zheng L, Yang Y, Da Lu GC, Salvato MS. 2005. Extracellular HIV Tat and Tat cysteine rich peptide increase CCR5 expression in monocytes. J Zhejiang Univ Sci. 6B(7):668–672.
   Google Scholar